Roger Sawhney - 04 Aug 2025 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney
Issuer symbol
ABUS
Transactions as of
04 Aug 2025
Net transactions value
$0
Form type
4
Filing time
06 Aug 2025, 16:08:29 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sawhney Roger Director C/O ARBUTUS BIOPHARMA CORPORATION, 701 VETERANS CIRCLE, WARMINSTER /s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney 06 Aug 2025 0001858748

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $0 +157,600 $0.000000 157,600 04 Aug 2025 Common Shares 157,600 $3.34 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
F2 This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.